BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38416545)

  • 1. Extended Enrichment for Ultrasensitive Detection of Low-Frequency Mutations by Long Blocker Displacement Amplification.
    Si Y; Wang X; Su X; Weng Z; Hu Q; Li Q; Fan C; Zhang DY; Wang Y; Luo S; Song P
    Angew Chem Int Ed Engl; 2024 May; 63(19):e202400551. PubMed ID: 38416545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Tube qPCR Detection and Quantitation of Hotspot Mutations Down to 0.01% Variant Allele Fraction.
    Zhang K; Rodriguez L; Cheng LY; Wang M; Zhang DY
    Anal Chem; 2022 Jan; 94(2):934-943. PubMed ID: 34932306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a highly sensitive Sanger sequencing in detecting EGFR mutations from circulating tumor DNA in patients with lung cancers.
    Jiang H; Chen X; Huang F; Xu X; Dong B; Luo J; Yang H; Zhang C; Pan B; Wang B; Guo W
    Clin Chim Acta; 2022 Nov; 536():98-103. PubMed ID: 36154839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens.
    Cheng LY; Haydu LE; Song P; Nie J; Tetzlaff MT; Kwong LN; Gershenwald JE; Davies MA; Zhang DY
    Sci Rep; 2021 Apr; 11(1):9043. PubMed ID: 33907234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Efficient Sequence-Based Nonextensible Oligonucleotide in Real-Time PCR and High-Throughput Sequencing.
    Zhang K; Song P; Dai P; Zhang JX; Wu LR; Cheng LY; Pinto A; Kwong L; Cabrera K; Wen R; Zhang DY
    ACS Sens; 2022 Apr; 7(4):1165-1174. PubMed ID: 35418222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective multiplexed enrichment for the detection and quantitation of low-fraction DNA variants via low-depth sequencing.
    Song P; Chen SX; Yan YH; Pinto A; Cheng LY; Dai P; Patel AA; Zhang DY
    Nat Biomed Eng; 2021 Jul; 5(7):690-701. PubMed ID: 33941896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly Sensitive Blocker Displacement Amplification for Detection of Low-Level JAK2V617F Variant.
    Wang Z; Weller C; Pinto A; Zhang DY; Mularo F; Tu ZJ; Cheng YW
    J Appl Lab Med; 2023 May; 8(3):479-490. PubMed ID: 36759689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirming putative variants at ≤ 5% allele frequency using allele enrichment and Sanger sequencing.
    Yan YH; Chen SX; Cheng LY; Rodriguez AY; Tang R; Cabrera K; Zhang DY
    Sci Rep; 2021 Jun; 11(1):11640. PubMed ID: 34079006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer.
    Akkhasutthikun P; Kaewsapsak P; Nimsamer P; Klomkliew P; Visedthorn S; Chanchaem P; Teerapakpinyo C; Payungporn S; Luangdilok S
    Cancer Res Treat; 2024 Apr; 56(2):455-463. PubMed ID: 37986562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers.
    Haley L; Tseng LH; Zheng G; Dudley J; Anderson DA; Azad NS; Gocke CD; Eshleman JR; Lin MT
    Mod Pathol; 2015 Oct; 28(10):1390-9. PubMed ID: 26226847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations.
    Poole JC; Wu SF; Lu TT; Vibat CRT; Pham A; Samuelsz E; Patel M; Chen J; Daher T; Singh VM; Arnold LJ
    PLoS One; 2019; 14(10):e0223112. PubMed ID: 31581267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.
    Nagakubo Y; Hirotsu Y; Amemiya K; Oyama T; Mochizuki H; Omata M
    BMC Med Genomics; 2019 Nov; 12(1):162. PubMed ID: 31711486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed enrichment of rare DNA variants via sequence-selective and temperature-robust amplification.
    Wu LR; Chen SX; Wu Y; Patel AA; Zhang DY
    Nat Biomed Eng; 2017; 1():714-723. PubMed ID: 29805844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced asymmetric blocked qPCR method for affordable detection of point mutations in KRAS oncogene.
    Lázaro A; Tortajada-Genaro LA; Maquieira Á
    Anal Bioanal Chem; 2021 May; 413(11):2961-2969. PubMed ID: 33619642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing methodologies to detect low-frequency mutations: "Catch me if you can".
    Menon V; Brash DE
    Mutat Res Rev Mutat Res; 2023; 792():108471. PubMed ID: 37716438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eprobe-mediated screening system for somatic mutations in the KRAS locus.
    Atsumi J; Hanami T; Enokida Y; Ogawa H; Delobel D; Mitani Y; Kimura Y; Soma T; Tagami M; Takase Y; Ichihara T; Takeyoshi I; Usui K; Hayashizaki Y; Shimizu K
    Oncol Rep; 2015 Jun; 33(6):2719-27. PubMed ID: 25823645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclease Enrichment and qPCR Detection of Rare Nucleotide Variants.
    Keraite I; Alvarez-Garcia V; Leslie NR
    Methods Mol Biol; 2023; 2621():41-56. PubMed ID: 37041439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection.
    Zapparoli GV; Jorissen RN; Hewitt CA; McBean M; Westerman DA; Dobrovic A
    BMC Cancer; 2013 Apr; 13():206. PubMed ID: 23617802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-blocker: a simple and robust probe-free quantitative PCR assay to detect somatic mutations down to 0.1% frequency.
    Kim H; Ruby AE; Shandilya HG; Virmani AK; Rahman N; Strange CM; Huuskonen J
    Biotechniques; 2018 Oct; 65(4):205-210. PubMed ID: 30284934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.
    Altimari A; de Biase D; De Maglio G; Gruppioni E; Capizzi E; Degiovanni A; D'Errico A; Pession A; Pizzolitto S; Fiorentino M; Tallini G
    Onco Targets Ther; 2013; 6():1057-64. PubMed ID: 23950653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.